Home Newsfeeds Benchmark Reiterates Buy on Marcus, Maintains $20 Price Target

Benchmark Reiterates Buy on Marcus, Maintains $20 Price Target

Benchmark analyst Mike Hickey reiterates Marcus (NYSE:MCS) with a Buy and maintains $20 price target.

byBenzinga Newsdesk

March 6, 2023

1 minute read

Benchmark analyst Mike Hickey reiterates Marcus (NYSE:MCS) with a Buy and maintains $20 price target.

Wells Fargo Upgrades Pioneer Natural Resources to Equal-Weight, Lowers Price Target to $220

By Benzinga Newsdesk

March 3, 5:48 AM

Wells Fargo analyst Roger Read upgrades Pioneer Natural Resources (NYSE:PXD) from Underweight to Equal-Weight and lowers the price target from $225 to $220.

PXD

Cowen & Co. Maintains Outperform on MediWound, Adjusts Price Target to $25 – 1-for-7 Reverse Stock Split

By Benzinga Newsdesk

December 30, 10:10 AM

Cowen & Co. analyst Joshua Jennings maintains MediWound (NASDAQ:MDWD) with a Outperform, adjusts price target to $25 - 1-for-7 reverse stock split.

MDWD

The Gift That Keeps On Giving: 2 Dividend Kings Increasing Dividend For Over 50 Years

By Robert Kuczmarski

August 27, 2:59 PM

Stocks that are members of the S&P 500 and have raised dividends for 25 consecutive years are commonly known as dividend aristocrats. However, there is a class of dividend stocks that are even more prestigious than dividend aristocrats and are known as dividend kings.

AWR